← Back to Search

Behavioral Intervention

Reciprocal Imitation Training for Autism

N/A
Recruiting
Led By Wendy L Stone, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
The child has a diagnosis of ASD or displays social communication impairments
Be younger than 18 years old
Must not have
The parent or child has previously received RIT or coaching in another NDBI
The child has visual, hearing, or motor conditions that would compromise his/her ability to participate in RIT or assessments
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 9 months
Awards & highlights
No Placebo-Only Group

Summary

This study is evaluating whether a parent-mediated intervention can improve outcomes for children with autism.

Who is the study for?
This trial is for children with Autism Spectrum Disorder (ASD) or social communication impairments who attend weekly sessions with a provider. Parents or guardians must be over 18, speak English or Spanish, and have not received Reciprocal Imitation Training (RIT) before. Children with visual, hearing, or motor conditions that affect RIT participation are excluded.
What is being tested?
The study aims to improve early intervention services for children with ASD by training providers in the Part C Early Intervention system to use an evidence-based parent-mediated approach called Reciprocal Imitation Training (RIT).
What are the potential side effects?
Since this trial involves educational and behavioral interventions rather than medical treatments, traditional side effects are not applicable. However, there may be varying responses to the training from both children and parents.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child has been diagnosed with autism or has trouble communicating socially.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My child or I have had therapy or coaching in a developmental intervention before.
Select...
My child has conditions affecting sight, hearing, or movement that may limit participation in the therapy or assessments.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 9 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 9 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adapted Motor Imitation Scale (MIS)
CI-RIT Caregiver Fidelity Form
Initiation of Joint Attention
+4 more
Secondary study objectives
Family Life Impairment Scale (FLIS)
Language Environment Analysis (LENA) Vocal Complexity
Language Environment Analysis (LENA) Vocal Contingency
+2 more
Other study objectives
Developmental Play Assessment (DPA
Parenting Stress Index-Short Form
Vineland-3

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: RIT Training GroupExperimental Treatment1 Intervention
Providers in the RIT group (n=80) will receive intensive training (online tutorial, 2-day workshop, and virtual coaching and feedback in the field) in RIT and parent coaching and will be required to achieve fidelity prior to enrolling families from their caseload. They will then be asked to use the intervention with enrolled families for a minimum of 3 months. One intervention session per month for each enrolled family will be videotaped and scored for fidelity. Providers will receive monthly consultation from RIT trainers while these families are in the active treatment phase.
Group II: Treatment as UsualActive Control1 Intervention
Providers in the TAU group (n=80) will have three sessions videotaped and scored for each enrolled family to assess treatment differentiation. To incentivize agency participation, RIT training will be provided to the TAU group and other providers when data collection is complete.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Parent-mediated interventions for Autism Spectrum Disorder (ASD) involve training parents to implement evidence-based strategies to enhance their child's social communication and behavioral skills. These strategies include modeling appropriate behaviors, using reinforcement to encourage desired actions, and engaging in structured play activities. The primary mechanism of action is the consistent and intensive support provided by parents in the child's natural environment, which can lead to more significant and sustained developmental improvements. This approach is particularly important for ASD patients as it utilizes the child's existing support system, making the intervention more accessible and potentially more effective over time.
Research-Based Intervention (RBI) for Autism Spectrum Disorder: Looking beyond Traditional Models and Outcome Measures for Clinical Trials.What are we targeting when we treat autism spectrum disorder? A systematic review of 406 clinical trials.Parent-mediated early intervention for young children with autism spectrum disorders (ASD).

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,827 Previous Clinical Trials
1,906,374 Total Patients Enrolled
17 Trials studying Autism Spectrum Disorder
3,809 Patients Enrolled for Autism Spectrum Disorder
Michigan State UniversityOTHER
198 Previous Clinical Trials
685,315 Total Patients Enrolled
8 Trials studying Autism Spectrum Disorder
1,429 Patients Enrolled for Autism Spectrum Disorder
National Institute of Mental Health (NIMH)NIH
2,931 Previous Clinical Trials
2,744,593 Total Patients Enrolled
84 Trials studying Autism Spectrum Disorder
40,812 Patients Enrolled for Autism Spectrum Disorder
Rush University Medical CenterOTHER
438 Previous Clinical Trials
250,012 Total Patients Enrolled
4 Trials studying Autism Spectrum Disorder
144 Patients Enrolled for Autism Spectrum Disorder
University of Massachusetts, BostonOTHER
36 Previous Clinical Trials
15,338 Total Patients Enrolled
2 Trials studying Autism Spectrum Disorder
112 Patients Enrolled for Autism Spectrum Disorder
Wendy L Stone, PhDPrincipal InvestigatorUniversity of Washington
3 Previous Clinical Trials
759 Total Patients Enrolled
2 Trials studying Autism Spectrum Disorder
718 Patients Enrolled for Autism Spectrum Disorder

Media Library

Reciprocal Imitation Training (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05114538 — N/A
Autism Spectrum Disorder Research Study Groups: RIT Training Group, Treatment as Usual
Autism Spectrum Disorder Clinical Trial 2023: Reciprocal Imitation Training Highlights & Side Effects. Trial Name: NCT05114538 — N/A
Reciprocal Imitation Training (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05114538 — N/A
~50 spots leftby May 2025